Multiple sclerosis: Symptomatic therapies

被引：23

作者：

Metz, L

机构：

[1] Univ Calgary, Foothills Hosp, MS Clin, Calgary, AB T2N 2T9, Canada

[2] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada

来源：

SEMINARS IN NEUROLOGY | 1998年 / 18卷 / 03期

关键词：

multiple sclerosis; symptoms; therapeutics;

D O I：

10.1055/s-2008-1040888

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Although new disease-altering treatments offer hope for those with multiple sclerosis, they are not appropriate for most. Management of symptoms, however, can help everyone with the disease. Several new therapies, including tizanidine, intrathecal baclofen, botulinum toxin injections, gabapentin, ondansitron, thalamic stimulation, and lamotrigine, increase our treatment options. Better understanding of the sleep disorders that commonly occur in those with multiple sclerosis will help us treat another disabling symptom. This chapter reviews the medical and surgical management of multiple sclerosis symptoms, including these new options.

引用

收藏

页码：389 / 395

页数：7

相关论文

共 48 条

[1] THE CLINICAL MANAGEMENT OF SPASTICITY [J].

ALONSO, RJ ;

MANCALL, EL .

SEMINARS IN NEUROLOGY, 1991, 11 (03) :215-219

[2] Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up [J].

Azouvi, P ;

Mane, M ;

Thiebaut, JB ;

Denys, P ;

RemyNeris, O ;

Bussel, B .

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (01) :35-39

[3] LONG-TERM INTRATHECAL BACLOFEN THERAPY IN PATIENTS WITH INTRACTABLE SPASTICITY [J].

BECKER, WJ ;

HARRIS, CJ ;

LONG, ML ;

ABLETT, DP ;

KLEIN, GM ;

DEFORGE, DA .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 22 (03) :208-217

[4] Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders [J].

Benabid, AL ;

Pollak, P ;

Gao, DM ;

Hoffmann, D ;

Limousin, P ;

Gay, E ;

Payen, I ;

Benazzouz, A .

JOURNAL OF NEUROSURGERY, 1996, 84 (02) :203-214

[5]

BETTS CD, 1993, J NEUROL NEUROSUR PS, V56, P250

[6] Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: Results of a randomized, double-blind, placebo-controlled, crossover trial [J].

Bever, CT ;

Anderson, PA ;

Leslie, J ;

Panitch, HS ;

DhibJalbut, S ;

Khan, OA ;

Milo, R ;

Hebel, JR ;

Conway, KL ;

Katz, E ;

Johnson, KP .

NEUROLOGY, 1996, 47 (06) :1457-1462

[7] Sildenafil, a novel effective oral therapy for male erectile dysfunction [J].

Boolell, M ;

GepiAttee, S ;

Gingell, JC ;

Allen, MJ .

BRITISH JOURNAL OF UROLOGY, 1996, 78 (02) :257-261

[8]

BORGSTEIN J, 1993, AM J PHYS MED REHAB, V72, P364

[9] SLEEP DISTURBANCE, DEPRESSION, AND LESION SITE IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].

CLARK, CM ;

FLEMING, JA ;

LI, D ;

OGER, J ;

KLONOFF, H ;

PATY, D .

ARCHIVES OF NEUROLOGY, 1992, 49 (06) :641-643

[10] TETRAHYDROCANNABINOL FOR TREMOR IN MULTIPLE-SCLEROSIS [J].

CLIFFORD, DB .

ANNALS OF NEUROLOGY, 1983, 13 (06) :669-671

← 1 2 3 4 5 →